CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Stein Steven H CMO & Head of Late-Stage Dev. | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +42,298 | 42,298 | ||
| 2026-07-16 | Meury William Chief Executive Officer | Grant or award | +26,807 | 183,129 | ||
| 2026-07-16 | Meury William Chief Executive Officer | Grant or award · Performance Shares | +80,421 | 80,421 | ||
| 2026-07-16 | Meury William Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +77,148 | 77,148 | ||
| 2026-07-16 | CAGNONI PABLO J President, Global Head of R&D | Grant or award | +13,403 | 231,332 | ||
| 2026-07-16 | CAGNONI PABLO J President, Global Head of R&D | Grant or award · Performance Shares | +33,508 | 33,508 | ||
| 2026-07-16 | CAGNONI PABLO J President, Global Head of R&D | Grant or award · Employee Stock Option (right to buy) | +57,861 | 57,861 | ||
| 2026-07-15 | Mayes Patrick A EVP & Chief Scientific Officer | Shares withheld for taxes | −1,512 | $115.09 | $174K | 57,712 |
| 2026-07-15 | Issa Mohamed Khairie EVP, Head of U.S. Commercial | Shares withheld for taxes | −1,099 | $115.09 | $126K | 65,033 |
| 2026-07-15 | Tray Thomas Principal Accounting Officer | Shares withheld for taxes | −1,098 | $115.09 | $126K | 18,865 |
| 2026-07-15 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −28,237 | $113.05 | $3.2M | 26,083 |
| 2026-07-15 | Stein Steven H CMO & Head of Late-Stage Dev. | Shares withheld for taxes 10b5-1 | −3,088 | $115.09 | $355K | 22,995 |
| 2026-07-15 | CAGNONI PABLO J President, Global Head of R&D | Shares withheld for taxes | −4,950 | $115.09 | $570K | 217,929 |
| 2026-07-14 | Mayes Patrick A EVP & Chief Scientific Officer | Shares withheld for taxes | −437 | $114.88 | $50K | 59,224 |
| 2026-07-14 | Tray Thomas Principal Accounting Officer | Shares withheld for taxes | −692 | $114.88 | $79K | 19,963 |
| 2026-07-14 | Stein Steven H CMO & Head of Late-Stage Dev. | Shares withheld for taxes 10b5-1 | −21,830 | $114.88 | $2.5M | 54,320 |
| 2026-07-14 | CAGNONI PABLO J President, Global Head of R&D | Shares withheld for taxes | −17,969 | $114.88 | $2.1M | 222,879 |
| 2026-07-02 | Mayes Patrick A EVP & Chief Scientific Officer | Shares withheld for taxes | −350 | $116.86 | $41K | 59,661 |
| 2026-07-02 | Tray Thomas Principal Accounting Officer | Shares withheld for taxes | −477 | $116.86 | $56K | 20,655 |
| 2026-07-02 | Stein Steven H CMO & Head of Late-Stage Dev. | Shares withheld for taxes | −2,177 | $116.86 | $254K | 76,150 |
Page 8 of 15 · 293 trades